multi pics
Volume 3, Issue 2
In this Issue...

> Introduction to This Issue of The Bridge
> "What Patients Want" and the Pharmacotherapy Implementation Gap
> Enhancing Meaningful Recovery: The Role of Treatment Programs in Expanding Access to Medication
> The Need for Patient and Family Demand for Pharmacotherapies
> Attitudes, Desires and Orientation of Patients and the Demand For or Acceptance of Pharmacotherapies
> Family and Patient Education on Using Medication to Support Recovery

> Macroscopic Issues in Consumer Knowledge about Pharmacotherapies

Blueline

> Introduction to This Issue of The Bridge
By Paul Roman, PhD, Editor
Improving the quality of the treatment of substance use disorders (SUDs) is the theme of a multifaceted campaign that has touched nearly every treatment provider organization and individual treatment professional for more than two decades. Read More...

Blueline

>"What Patients Want" and the Pharmacotherapy Implementation Gap
By Hannah K. Knudsen, Jamie L. Studts, and William W. Stoops, University of Kentucky
Collectively, we as health services researchers have not fully grappled with the question, "What do patients want as part of SUD treatment?" and the implications of the answers to that question. Read More...

Blueline

> Enhancing Meaningful Recovery: The Role of Treatment Programs in Expanding Access to Medication
By Louise Haynes, Medical University of South Carolina
For a variety of reasons, many substance use disorder (SUD) treatment programs have been slow to adopt medications in their array of services. Read More...

Blueline

> The Need for Patient and Family Demand for Pharmacotherapies
By Michael Boyle, University of Wisconsin
The barriers to the use of pharmacotherapies for the treatment of substance use illnesses are substantial. If these substantial hurdles are to be overcome, a new force is needed, which is demand for these medications from patients and their families.  Read More...

Blueline

>Attitudes, Desires and Orientation of Patients and the Demand For or Acceptance of Pharmacotherapies
By Holly Hagle, National SBIRT ATTC
I have to ask, "What stands in the way of broader acceptance and use of SBIRT and MAT?" Unfortunately it seems like there is currently neither a demand for nor an acceptance of pharmacotherapies for substance use disorders.  Read More...

Blueline

> Family and Patient Education on Using Medication to Support Recovery
By Dennis McCarty and Raina Croff, Oregon Health and Science University, and Mady Chalk, Kelly Alanis-Hirsch Treatment Research Institute
Counselors, patients and families believe that addiction treatment relies on development of sobriety skills and that the use of medication inhibits the development. Unfortunately, this belief continues to impede adoption of new medications that enhance response to care. Read More...

Blueline

> Macroscopic Issues in Consumer Knowledge about Pharmacotherapies
By Paul M. Roman, University of Georgia
A quick solution is not available as to how to create not only awareness of new treatments but readiness to use them. Read More...

Blueline

Download a PDF of this entire issue


The Bridge is a semi-annual e-pub that links science and service by providing information and tools on technology transfer and implementation science strategies.


Points of Interest...

Follow us on TwitterJoin Us for a "Twitter Chat"
Wed, October 16, 2013
4pm Eastern/3pm Central
@ATTCnetwork #attcbridge

Blueline

Download a PDF of this entire issue





Are you interested in contributing to the next issue of The Bridge?

Contact Paul Roman, Editor of The Bridge, or send an email to thebridge@attcnetwork.org.

We want to hear from you!
Email your thoughts about this issue of The Bridge to Maureen Fitzgerald at the ATTC Network Coordinating Office.

The Bridge Editorial Board

Subscribe to The Bridge

Connect with us to join the conversation online!

Find us on Facebook Follow us on Twitter Join us on LinkedIn Watch us on YouTube